NSC |
Compound |
Enrichment |
Correlation |
NSC 627745 |
Null |
0.0119653763676522 |
0.25348088 |
NSC 102225 |
Null |
0.0133986477026051 |
0.23192197 |
NSC 114340 |
Ophiobolin A |
0.0133986477026051 |
0.023147556 |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.0133986477026051 |
0.22836383 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0133986477026051 |
0.21957571 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0133986477026051 |
0.062560516 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0133986477026051 |
0.15002807 |
NSC 261726 |
ICN 4221 |
0.0133986477026051 |
0.23211765 |
NSC 330507 |
Tanespimycin |
0.0133986477026051 |
-0.034202216 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.0133986477026051 |
0.14203998 |